Colchicine Dosing Regimens for Gout Management

Acute Gout Treatment

The American College of Rheumatology recommends colchicine should be administered as a loading dose of 1.2 mg followed by 0.6 mg one hour later (total 1.8 mg), and should only be used if started within 36 hours of symptom onset 1, 2
Colchicine should only be used for gout attacks with onset within the previous 36 hours, as effectiveness significantly decreases beyond this timeframe 1, 3, 2
After the initial doses, continue with prophylactic dosing of 0.6 mg once or twice daily (beginning 12 hours after the initial doses) until the gout attack resolves 1, 2
Low-dose colchicine (1.8 mg total over 1 hour) is as effective as higher doses with significantly fewer side effects 2

For gout flare prophylaxis, the recommended dose is 0.6 mg once or twice daily 1, 2
Prophylaxis should be initiated with or just prior to starting urate-lowering therapy 1, 2
Continue prophylaxis for at least 6 months, or 3 months after achieving target serum urate (if no tophi detected on physical exam), or 6 months after achieving target serum urate (if tophi are present) 1, 2, 4

For patients with severe renal impairment, reduce the dose to a single dose of 0.6 mg with no repeat treatment for at least two weeks 2, 4
For patients on dialysis, a single dose of 0.6 mg should be administered and not repeated before two weeks 4
Dose reduction is required with concomitant use of moderate to high potency inhibitors of CYP3A4 and P-glycoprotein 2
Major drug interactions requiring dose adjustment include clarithromycin, erythromycin, cyclosporine, and disulfiram 3, 2

The American College of Rheumatology recommends NSAIDs at full FDA-approved doses until complete resolution of the crisis 1, 5
Corticosteroids, such as prednisone 0.5 mg/kg/day for 5-10 days, then stopped or tapered over 7-10 days 1, 4
Intra-articular injections of corticosteroids (dose varies depending on joint size) for involvement of 1-2 large joints 1, 3

The American Journal of Kidney Diseases recommends low-dose colchicine (1.2 mg followed by 0.6 mg one hour later) for patients with CKD and acute gout flare if eGFR ≥30 mL/min 6
Treatment must be initiated within 12-36 hours of symptom onset for effectiveness, as stated by the Annals of the Rheumatic Diseases 7
The Annals of the Rheumatic Diseases also recommends that colchicine should be avoided in patients with severe renal impairment (eGFR <30 mL/min) 7

For patients with severe renal impairment (eGFR <30 mL/min), the American Journal of Kidney Diseases recommends glucocorticoids as the preferred first-line treatment over colchicine 6
The Annals of the Rheumatic Diseases suggests oral corticosteroids, such as prednisone 30-35 mg/day, for 3-5 days as an alternative treatment 7
Intra-articular corticosteroid injection is also recommended for single or few joint involvement by the Annals of the Rheumatic Diseases 7

The Annals of the Rheumatic Diseases states that colchicine is absolutely contraindicated with strong P-glycoprotein and/or CYP3A4 inhibitors in patients with CKD 7
The American Journal of Kidney Diseases recommends avoiding concurrent use of colchicine with cyclosporine, clarithromycin, erythromycin, ketoconazole, itraconazole, verapamil, diltiazem, or ritonavir/nirmatrelvir (Paxlovid) 6

The Annals of the Rheumatic Diseases recommends calculating eGFR immediately when considering colchicine for acute gout 7
Screening for drug interactions with CYP3A4/P-glycoprotein inhibitors is also recommended by the Annals of the Rheumatic Diseases and the American Journal of Kidney Diseases 6, 7